Your interview with French president Emmanuel Macron has left me with more questions than answers (February 19). He is dissatisfied with the supply of the vaccine to poorer nations, yet does not comment on the state of the (relatively modest) rollout in France. He singles out AstraZeneca as a company whose product is being sold to these nations “at astronomical prices”, despite the chief executive, Pascal Soriot, a countryman of Macron, having undertaken to sell it at cost.
Macron has rubbished the Oxford/AstraZeneca vaccine (and Britain) at every turn. Can we assume that France will offload its stock of this product on hapless developing nations as Macron doesn’t seem to want it for France?
It would have been interesting had Macron updated us on the progress of the Sanofi vaccine. This interview seemed to me like a diversionary tactic.
Elizabeth Balsom
London SW15, UK
"tactic" - Google News
February 23, 2021 at 12:00PM
https://ift.tt/3btGsPi
Letter: I detect a diversionary tactic by the French leader - Financial Times
"tactic" - Google News
https://ift.tt/2NLbO9d
Shoes Man Tutorial
Pos News Update
Meme Update
Korean Entertainment News
Japan News Update
Bagikan Berita Ini
0 Response to "Letter: I detect a diversionary tactic by the French leader - Financial Times"
Post a Comment